Hormone receptor negative HER2 positive breast cancer represents a unique form of breast cancer where cancer cells produce excessive amounts of the HER2 protein but do not respond to hormones like estrogen or progesterone. This particular combination affects how the disease behaves and which treatments may work best for patients.
Understanding This Type of Breast Cancer
Breast cancer is not a single disease but rather a group of different conditions that behave in distinct ways. To understand what kind of breast cancer someone has, doctors look at specific characteristics of the cancer cells, which are called biomarkers. These biomarkers help doctors decide which treatments will be most effective for each person. Three important biomarkers that doctors test for are the estrogen receptor, the progesterone receptor, and a protein called HER2, which stands for human epidermal growth factor receptor 2.[2]
When breast cancer cells contain high levels of HER2 protein on their surface, the condition is called HER2 positive breast cancer. Around fifteen to twenty percent of all breast cancer cases fall into this category. In healthy cells, HER2 helps regulate normal cell growth and other essential processes. However, when cancer cells produce excessive amounts of HER2, it acts like fuel for the cancer, causing tumors to grow faster than they would otherwise.[2][10]
HER2 positive breast cancer can also be classified based on whether the cancer cells have hormone receptors. Hormone receptors are special proteins inside cells that allow hormones like estrogen and progesterone to attach to them. When these hormones connect to the receptors, they can signal cancer cells to grow and multiply. Some breast cancers are hormone receptor positive, meaning they need these hormones to grow. Others are hormone receptor negative, meaning they do not have these receptors and do not depend on hormones to fuel their growth.[3]
Hormone receptor negative HER2 positive breast cancer is a specific subtype where the cancer cells produce excessive amounts of HER2 but do not have receptors for estrogen or progesterone. This means the cancer grows because of the HER2 protein, not because of hormones. This combination makes the cancer behave differently from other types and requires specific treatment approaches.[2][10]
How Common Is This Type of Breast Cancer
Breast cancer is the most common cancer diagnosed in women worldwide, with more than 1.3 million new cases and 450,000 deaths occurring each year. The vast majority of patients with a new breast cancer diagnosis have early stage disease, meaning the cancer has not spread extensively beyond the breast.[5]
Among all breast cancers, approximately fifteen to twenty percent are HER2 positive. This means that out of every five women diagnosed with breast cancer, roughly one will have cancer cells that produce excessive amounts of the HER2 protein. However, not all HER2 positive breast cancers are hormone receptor negative. Many HER2 positive breast cancers are also hormone receptor positive, meaning they respond to both HER2 and hormones.[2][10]
When looking at hormone receptor status across all breast cancers, about seventy to eighty percent are hormone receptor positive. This means they have receptors for estrogen, progesterone, or both. The remaining twenty to thirty percent are hormone receptor negative, meaning they lack these receptors. Within this hormone receptor negative group, some cancers are HER2 positive, while others are HER2 negative.[3][5]
The combination of being both hormone receptor negative and HER2 positive is less common than other breast cancer subtypes. It represents a smaller proportion of all breast cancer diagnoses compared to hormone receptor positive HER2 negative breast cancer, which accounts for about seventy percent of all cases.[1][9]
What Causes This Form of Breast Cancer
Breast cancer develops when the DNA inside breast cells undergoes changes, called mutations, that transform them into cancer cells. These altered cells then divide uncontrollably and form tumors. Scientists discovered the link between the HER2 gene and cancer formation in the 1980s. Research showed that a mutation in the HER2 gene stimulated cells to grow and divide excessively, leading to the development of cancer.[6][9]
In normal cells, the HER2 gene produces a protein that sits on the cell surface and helps regulate cell growth. When the gene functions properly, it produces the right amount of HER2 protein. However, when mutations occur, the gene can become overactive, causing cells to produce far too much HER2 protein. This excess protein acts as a signal that tells cells to grow and divide rapidly, even when they should not. This uncontrolled growth is what leads to the formation of cancerous tumors.[6]
Scientists do not fully understand why some breast cancers develop with high levels of HER2 but no hormone receptors, while others develop with different combinations of biomarkers. The specific mutations that lead to hormone receptor negative HER2 positive breast cancer remain an area of ongoing research. What is clear is that these cancers have different biological characteristics that affect how they grow and how they respond to treatment.[9]
Risk Factors That May Increase Your Chances
While experts do not know exactly what causes the specific mutations that lead to hormone receptor negative HER2 positive breast cancer, they have identified several factors that increase the overall risk of developing breast cancer in general. Understanding these risk factors can help people be more aware of their breast health and take appropriate screening measures.[1][9]
Inherited genetic mutations play an important role in breast cancer risk. While there is no specific mutation that causes only HER2 related breast cancers, inheriting mutations in genes called BRCA1 or BRCA2 significantly increases the overall risk of developing breast cancer. People who carry these genetic mutations have a much higher lifetime risk of breast cancer compared to those who do not carry these mutations.[1][9]
Personal and family history also matters significantly. If you have been diagnosed with breast cancer before, your risk of developing it again increases. Similarly, having close biological relatives with breast cancer, especially a parent, sibling, or child, raises your risk. This is because family members often share genetic factors that can make breast cancer more likely to develop.[1][9]
Long term exposure to high levels of estrogen or progesterone throughout a person’s lifetime can also increase breast cancer risk. This can happen if someone starts their menstrual period at an especially early age or begins menopause later than average. Both of these situations increase the total number of years that breast tissue is exposed to hormones. Additionally, some forms of hormone therapy used for other medical conditions can increase breast cancer risk depending on the type and duration of use.[1][9]
Recognizing the Symptoms
The symptoms of hormone receptor negative HER2 positive breast cancer are the same as those of breast cancer in general. The specific biomarker characteristics of the cancer do not change what symptoms a person might experience. It is important to know what to look for because early detection often leads to better treatment outcomes.[1][9]
Changes in the size or shape of your breast are common warning signs. You might notice that one breast appears different from the other, or that a breast has changed in appearance compared to how it looked previously. These changes might develop gradually or appear more suddenly, and they may or may not be accompanied by pain or discomfort.[1][9]
Finding a new lump or hardened area in or near your breast or armpit is another important symptom to watch for. This lump might feel different from the surrounding tissue and typically does not change in response to your menstrual cycle. Not all lumps are cancerous, but any new lump that persists should be evaluated by a healthcare provider.[1][9]
Skin changes affecting the breast or nipple can also signal breast cancer. The skin might become dimpled, puckered, scaly, or itchy. Color changes are also significant, such as the skin appearing reddish, purple, or unusually dark. These changes occur because cancer can affect the lymphatic vessels in the skin, causing inflammation and altered appearance.[1][9]
Nipple discharge, especially if it is bloody or clear, should always be evaluated. Additionally, if your nipple begins to pull inward when it previously pointed outward, this change warrants medical attention. These symptoms can occur for reasons other than cancer, but they should never be ignored.[1][9]
One crucial point to remember is that breast cancer does not always cause visible or noticeable changes, particularly in its early stages. Many of the changes described above can also occur with noncancerous, or benign, conditions. This is why regular breast cancer screening through mammography is so important. Screening can detect cancer before symptoms appear, when it is often easier to treat.[1][9]
Prevention and Early Detection
While there is no guaranteed way to prevent breast cancer, including the hormone receptor negative HER2 positive type, there are steps people can take to potentially reduce their risk and ensure early detection if cancer does develop. Early detection is particularly important because breast cancer is generally more treatable when found at an earlier stage.
Regular breast cancer screening is one of the most effective tools for early detection. Screening mammography can find breast cancer before any symptoms appear. Healthcare providers recommend that women follow age appropriate screening guidelines, which typically involve starting regular mammograms at a certain age. People with higher risk factors, such as those with BRCA mutations or strong family history, may need to start screening earlier or have additional screening methods like breast MRI.
Being aware of your breast health and knowing what is normal for your body is also valuable. While formal self examination recommendations have changed over the years, being familiar with how your breasts normally look and feel can help you notice changes more quickly. If you do notice something unusual, seeing a healthcare provider promptly allows for timely evaluation.
For people who have inherited genetic mutations that significantly increase breast cancer risk, there are additional prevention options to discuss with healthcare providers. These might include more intensive screening protocols, medications that can reduce breast cancer risk, or in some cases, preventive surgeries. These decisions are highly personal and should be made after thorough discussion with knowledgeable healthcare professionals.
Maintaining overall health through lifestyle choices may also play a role in breast cancer risk. While lifestyle factors cannot eliminate risk entirely, some research suggests that maintaining a healthy weight, engaging in regular physical activity, limiting alcohol consumption, and avoiding smoking may contribute to lower breast cancer risk. However, even people who maintain excellent health habits can still develop breast cancer, so screening remains essential regardless of lifestyle.
How This Cancer Affects the Body
Understanding the biological processes behind hormone receptor negative HER2 positive breast cancer helps explain why this particular type behaves the way it does and why specific treatments are effective. The term pathophysiology refers to the changes in normal bodily functions that occur when disease is present.[6]
In normal breast tissue, cells grow, divide, and die in an orderly and controlled manner. Various proteins and signaling pathways regulate this process to ensure that cells only grow when needed and that old or damaged cells are removed. The HER2 protein is one of several growth factor receptors that help control cell growth under normal circumstances.[2][10]
When breast cancer cells have excessive amounts of HER2 protein on their surface, this normal control system breaks down. The overabundance of HER2 receptors means that growth signals are constantly being sent to the cells, even when growth should not be occurring. Think of it like a light switch that is stuck in the on position. The cells receive continuous instructions to grow and divide, leading to rapid tumor formation and growth.[2][10]
In hormone receptor positive breast cancers, the presence of estrogen and progesterone receptors provides another pathway through which cancer cells receive growth signals. However, in hormone receptor negative HER2 positive breast cancer, these hormone receptor pathways are not present. The cancer cells lack the receptors that would allow hormones to attach to them. This means the primary driver of growth in this cancer type is the excessive HER2 signaling, not hormone stimulation.[3]
This biological difference has important implications. HER2 positive breast cancers, regardless of hormone receptor status, tend to be more aggressive than some other breast cancer types. The excessive HER2 signaling promotes faster cell division, which means tumors can grow more quickly. However, the presence of high HER2 levels also provides a specific target for treatment. Modern targeted therapies have been developed that specifically block HER2 signaling, effectively disrupting the cancer’s main growth pathway.[2][10]
When cancer cells continue to grow unchecked, they form a mass or tumor in the breast. Over time, cancer cells can break away from the original tumor and spread to other parts of the body through the bloodstream or lymphatic system. This process is called metastasis. The lymph nodes in the armpit are often the first place where breast cancer spreads because lymph fluid from the breast naturally drains to these nodes. From there, cancer can potentially spread to more distant organs such as the bones, lungs, liver, or brain.[5]
The biological characteristics of hormone receptor negative HER2 positive breast cancer mean it requires treatment approaches specifically designed to target HER2. Unlike hormone receptor positive cancers, which can be treated with hormone blocking therapies, this cancer type will not respond to those medications because the cancer cells do not depend on hormones for growth. Instead, treatment focuses on blocking the HER2 pathway and using other therapies like chemotherapy to eliminate cancer cells.[3][12]
